Proteomic immunotherapy components and Hexabromodiphenyl antigens, based on yeast, are used for the infection, methods and uses of chronic hepatitis B.
Disclosed are yeast-based immunotherapeutic compositions, hepatitis B virus (HBV) antigens, and fusion proteins for the treatment and/or prevention of HBV infection and symptoms thereof, as well as methods of using the yeast-based immunotherapeutic compositions, HBV antigens, and fusion proteins for the prophylactic and/or therapeutic treatment of HBV and/or symptoms thereof.COMPOSICION INMUNOTERAPEUTICA DE PROTEINAS DE FUSION CON ANTIGENOS DEL HBV, A BASE DE LEVADURA PARA INFECCION DE LA HEPATITIS B CRONICA, METODOS Y USOS.